A Study of Different Use Regimens Using Two Acne Treatments
Completed
Bausch Health Americas, Inc.
Phase 4
2009-02-01
A study to determine if using 2 acne products in the morning is as safe and efficacious as
using one product in the morning and one product in the evening.
A Study of Different Use Regimens Using Two Acne Treatments
Completed
Valeant Pharmaceuticals International, Inc.
Phase 4
2009-02-01
A study to determine if using 2 acne products in the morning is as safe and efficacious as
using one product in the morning and one product in the evening.
Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin
Completed
Johnson & Johnson
Phase 4
2009-07-01
The use of topical retinoids is a mainstay and basis of early acne treatment to prevent the
progression to inflammatory lesions. Post oral isotretinoin, it is not uncommon for
non-inflammatory papules and comedones to recur. However, there has been no formal study to
look at the prevention of recurrence of these acne lesions post isotretinoin in a long term
basis. This may enhance the therapeutic options for post isotretinoin patients in order to
prevent recurrence of their disease.
Hypothesis Tretinoin microsphere 0.04% will prevent recurrence of acne lesions.
Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin
Completed
Dermatrials Research
Phase 4
2009-07-01
The use of topical retinoids is a mainstay and basis of early acne treatment to prevent the
progression to inflammatory lesions. Post oral isotretinoin, it is not uncommon for
non-inflammatory papules and comedones to recur. However, there has been no formal study to
look at the prevention of recurrence of these acne lesions post isotretinoin in a long term
basis. This may enhance the therapeutic options for post isotretinoin patients in order to
prevent recurrence of their disease.
Hypothesis Tretinoin microsphere 0.04% will prevent recurrence of acne lesions.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
